Cetera Advisors’s Dogwood Therapeutics DWTX Stock Holding History

Cetera Advisors’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$5.7K	Sell	476 -66	-12%	-$741	﹤0.01%	2417
2023 Q4	$7.8K	Hold	542	–	–	﹤0.01%	1780
2023 Q3	$12.5K	Hold	542	–	–	﹤0.01%	1689
2023 Q2	$18.7K	Sell	542 -279	-34%	-$7.96K	﹤0.01%	1635
2023 Q1	$7.54K	Hold	821	–	–	﹤0.01%	1640
2022 Q4	$4.84K	Sell	821 -937	-53%	-$7.06K	﹤0.01%	1595
2022 Q3	$17K	Hold	1,758	–	–	﹤0.01%	1252
2022 Q2	$186K	Hold	1,758	–	–	﹤0.01%	1256
2022 Q1	$197K	Buy	1,758 +318	+22%	+$46.3K	﹤0.01%	1309
2021 Q4	$184K	Sell	1,440 -497	-26%	-$63.2K	﹤0.01%	1342
2021 Q3	$256K	Buy	1,937 +968	+100%	+$134K	0.01%	1187
2021 Q2	$152K	Buy	969 +28	+3%	+$3.97K	﹤0.01%	1271
2021 Q1	$135K	Buy	+941	New	+$164K	﹤0.01%	1177

Other funds holding DWTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RFC

Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cetera Advisors's DWTX Position: Q1 2024 in Review

Cetera Advisors reduced its Dogwood Therapeutics (DWTX) stake by 12% in Q1 2024, selling an estimated $741 and leaving 476 shares worth $5.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2417.

Cetera Advisors first reported a position in DWTX in Q1 2021 and has held it in 13 quarters since. The position peaked at $256K in Q3 2021. 21 funds tracked by Wall St. Rank hold DWTX as of Q1 2024.

Cetera Advisors held 476 shares of Dogwood Therapeutics worth $5.7K as of Q1 2024.
Cetera Advisors sold 66 Dogwood Therapeutics shares in Q1 2024, an estimated $741.
Dogwood Therapeutics made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2417 holding.
Cetera Advisors first reported a position in Dogwood Therapeutics in Q1 2021 and has held it in 13 quarters since.
Cetera Advisors's Dogwood Therapeutics position peaked at $256K in Q3 2021.
21 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.